Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard LeDuc

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Organic & Biomolecular Chemistry|December 8, 2016
Structure-activity relationship of novel macrocyclic biased apelin receptor agonistsAlexandre Murza, Xavier Sainsily, Jérôme Côté, et al.
European Journal of Medicinal Chemistry|May 18, 2025
Optimizing the pharmacokinetics and selectivity of TMPRSS2 inhibitorsSára Ferková, Matthieu Lepage, Antoine Désilets, et al.
Scientific Reports|August 1, 2018
GRK2 knockdown in mice exacerbates kidney injury and alters renal mechanisms of blood pressure regulationElena Tutunea-Fatan, Khaled S Abd-Elrahman, Jean-Francois Thibodeau, et al.
Chemmedchem|October 21, 2023
Optimization of Ketobenzothiazole-Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus ReplicationÉloïc Colombo, Antoine Désilets, Malihe Hassanzadeh, et al.
Nature Communications|April 16, 2015
Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signallingGina L Zoratti, Lauren M Tanabe, Fausto A Varela, et al.
Oncotarget|August 17, 2016
Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancerGina L Zoratti, Lauren M Tanabe, Thomas E Hyland, et al.
Journal of Medicinal Chemistry|January 16, 2026
Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy <i>via</i> C-Terminal Peptide Engineering and Allosteric Site TargetingMargot Hadjadj, Malihe Hassanzadeh, Justin Martel, et al.
Pharmacoepidemiology and Drug Safety|November 19, 2016
Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortalitySylvie Perreault, Simon de Denus, Michel White, et al.
Science Signaling|August 8, 2023
Unraveling allostery within the angiotensin II type 1 receptor for Gα<sub>q</sub> and β-arrestin couplingYubo Cao, Wijnand J C van der Velden, Yoon Namkung, et al.
Journal of Medicinal Chemistry|March 18, 2016
Discovery and Structure-Activity Relationship of a Bioactive Fragment of ELABELA that Modulates Vascular and Cardiac FunctionsAlexandre Murza, Xavier Sainsily, David Coquerel, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Organic & Biomolecular Chemistry|December 8, 2016
Structure-activity relationship of novel macrocyclic biased apelin receptor agonistsAlexandre Murza, Xavier Sainsily, Jérôme Côté, et al.
European Journal of Medicinal Chemistry|May 18, 2025
Optimizing the pharmacokinetics and selectivity of TMPRSS2 inhibitorsSára Ferková, Matthieu Lepage, Antoine Désilets, et al.
Scientific Reports|August 1, 2018
GRK2 knockdown in mice exacerbates kidney injury and alters renal mechanisms of blood pressure regulationElena Tutunea-Fatan, Khaled S Abd-Elrahman, Jean-Francois Thibodeau, et al.
Chemmedchem|October 21, 2023
Optimization of Ketobenzothiazole-Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus ReplicationÉloïc Colombo, Antoine Désilets, Malihe Hassanzadeh, et al.
Nature Communications|April 16, 2015
Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signallingGina L Zoratti, Lauren M Tanabe, Fausto A Varela, et al.
Oncotarget|August 17, 2016
Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancerGina L Zoratti, Lauren M Tanabe, Thomas E Hyland, et al.
Journal of Medicinal Chemistry|January 16, 2026
Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy <i>via</i> C-Terminal Peptide Engineering and Allosteric Site TargetingMargot Hadjadj, Malihe Hassanzadeh, Justin Martel, et al.
Pharmacoepidemiology and Drug Safety|November 19, 2016
Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortalitySylvie Perreault, Simon de Denus, Michel White, et al.
Science Signaling|August 8, 2023
Unraveling allostery within the angiotensin II type 1 receptor for Gα<sub>q</sub> and β-arrestin couplingYubo Cao, Wijnand J C van der Velden, Yoon Namkung, et al.
Journal of Medicinal Chemistry|March 18, 2016
Discovery and Structure-Activity Relationship of a Bioactive Fragment of ELABELA that Modulates Vascular and Cardiac FunctionsAlexandre Murza, Xavier Sainsily, David Coquerel, et al.
Pageof 14